Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response
Clinical trial NCT01850004 · COMPLETED
Trial details
- NCT number
- NCT01850004
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-22
- Primary completion
- 2017-09-20
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.